REGEN BIOLOGICS INC 4
4 · REGEN BIOLOGICS INC · Filed Feb 23, 2009
Insider Transaction Report
Form 4
MCNEIL ROBERT G
Director10% Owner
Transactions
- Exercise/Conversion
Common Stock
2009-02-18$1.80/sh+62,500$112,500→ 74,486 total - Exercise/Conversion
Stock Option (Right to Buy)
2009-02-18−62,500→ 0 totalExercise: $1.80From: 2009-02-17Exp: 2017-10-18→ Common Stock (62,500 underlying)
Footnotes (2)
- [F1]The original exercise price was $0.09 per share of common stock of ReGen Biologics, Inc. (the "Company"); however, after the Company effected a 1 for 20 reverse split of its common stock on November 29, 2008 (the "Reverse Split"), the exercise price became $1.80 per share of common stock.
- [F2]The Company amended Mr. McNeil's Option Agreement dated October 18, 2007 on February 17, 2009 to allow for early exercise of the options issued pursuant to the Option Agreement. The Option Agreement provided for the issuance of 12,500 shares of Series E Preferred Stock of the Company upon exercise, or 62,500 shares of common stock immediately after mandatory conversion of the Series E Preferred Stock and after taking into account the Reverse Split. The Series E Preferred Stock manditorily converted upon effectiveness of the Reverse Split.